New hope for Tough-to-Treat colon cancer patients
Disease control
Recruiting now
This study is testing whether adding a new immunotherapy drug called isunakinra to an existing cancer drug (pembrolizumab) can help control advanced colorectal cancer that has spread or cannot be surgically removed. The trial is for patients whose cancer has specific genetic feat…
Phase: PHASE2 • Sponsor: Buzzard Pharmaceuticals • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC